934586-49-9 Usage
Uses
Used in Organic Synthesis:
1-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperidine is used as a synthetic intermediate for the creation of more complex organic molecules, leveraging its unique boron-containing group to facilitate specific chemical reactions and bond formations.
Used in Materials Science:
In the field of materials science, 1-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperidine may serve as a component in the development of new materials with tailored properties, such as those with enhanced thermal stability or specific optical characteristics, due to its structural features.
Used in Pharmaceutical Research:
1-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperidine is used as a potential lead compound in drug discovery, given its complex structure that may offer novel interactions with biological targets, potentially leading to the development of new therapeutic agents.
Used in Coordination Chemistry:
Due to its boron-containing group, 1-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperidine is used in coordination chemistry to explore its ability to form complexes with metal ions, which could have applications in catalysis or the creation of functional materials.
Check Digit Verification of cas no
The CAS Registry Mumber 934586-49-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,4,5,8 and 6 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 934586-49:
(8*9)+(7*3)+(6*4)+(5*5)+(4*8)+(3*6)+(2*4)+(1*9)=209
209 % 10 = 9
So 934586-49-9 is a valid CAS Registry Number.
InChI:InChI=1/C19H30BNO3/c1-18(2)19(3,4)24-20(23-18)16-8-10-17(11-9-16)22-15-14-21-12-6-5-7-13-21/h8-11H,5-7,12-15H2,1-4H3
934586-49-9Relevant academic research and scientific papers
Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutan
Wang, Aoli,Li, Xixiang,Chen, Cheng,Wu, Hong,Qi, Ziping,Hu, Chen,Yu, Kailin,Wu, Jiaxin,Liu, Juan,Liu, Xiaochuan,Hu, Zhenquan,Wang, Wei,Wang, Wenliang,Wang, Wenchao,Wang, Li,Wang, Beilei,Liu, Qingwang,Li, Lili,Ge, Jian,Ren, Tao,Zhang, Shanchun,Xia, Ruixiang,Liu, Jing,Liu, Qingsong
, p. 8407 - 8424 (2017/11/03)
FLT3-ITD mutant has been observed in about 30% of AML patients and extensively studied as a drug discovery target. On the basis of our previous study that ibrutinib (9) exhibited selective and moderate inhibitory activity against FLT3-ITD positive AML cel
Synthesis and growth inhibition activity of fluorinated derivatives of tamoxifen
Malo-Forest, Bianca,Landelle, Grégory,Roy, Jessye-Ann,Lacroix, Jacques,Gaudreault, René C.,Paquin, Jean-Fran?ois
, p. 1712 - 1715 (2013/03/29)
The design and synthesis of 11 fluorinated derivatives of tamoxifen are described. Growth inhibition values (GI50) on human HT-29, M21, MCF7, and MDA-MB-231 tumor cells are also reported. In general, the GI50 values are similar or sl
